EUVIMEDEUVIMED entdecken
Studienprotokoll

Comparative Toxicity and Survival Outcomes of LMB-96 Chemotherapy Protocol with or Without Rituximab in Pediatric High-Risk B-Cell Non-Hodgkin Lymphoma

SECI Oncology Journal · 28.04.2026 · 14 (2) · 63-71

DOI: 10.21608/secioj.2026.502155 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift SECI Oncology Journal, online erschienen am 28.04.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Comparative Toxicity and Survival Outcomes of LMB-96 Chemotherapy Protocol with or Without Rituximab in Pediatric High-Risk B-Cell Non-Hodgkin Lymphoma. SECI Oncology Journal, 14(2), 63-71. https://doi.org/10.21608/secioj.2026.502155

Vancouver

Comparative Toxicity and Survival Outcomes of LMB-96 Chemotherapy Protocol with or Without Rituximab in Pediatric High-Risk B-Cell Non-Hodgkin Lymphoma. SECI Oncology Journal. 2026;14(2):63-71. doi:10.21608/secioj.2026.502155

BibTeX
@article{euvimed2026,
  title = {Comparative Toxicity and Survival Outcomes of LMB-96 Chemotherapy Protocol with or Without Rituximab in Pediatric High-Risk B-Cell Non-Hodgkin Lymphoma},
  journal = {SECI Oncology Journal},
  year = {2026},
  volume = {14},
  number = {2},
  pages = {63--71},
  doi = {10.21608/secioj.2026.502155}
}
Kostenlos starten →